Header Logo

Connection

Stavros Stavrakis to Treatment Outcome

This is a "connection" page, showing publications Stavros Stavrakis has written about Treatment Outcome.
Connection Strength

1.774
  1. Impact of Frailty on In-Hospital Outcomes in Patients Undergoing Atrial Fibrillation Ablation. Am J Cardiol. 2023 08 15; 201:68-70.
    View in: PubMed
    Score: 0.135
  2. Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Preserved Systolic Function: A Long-Standing Conundrum. Am J Cardiol. 2023 Aug 01; 200:160-161.
    View in: PubMed
    Score: 0.135
  3. Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2021 05 01; 146:36-47.
    View in: PubMed
    Score: 0.115
  4. Autonomic Modulation of Cardiac Arrhythmias: Methods to Assess Treatment and Outcomes. JACC Clin Electrophysiol. 2020 05; 6(5):467-483.
    View in: PubMed
    Score: 0.109
  5. New approaches for treating atrial fibrillation: Focus on autonomic modulation. Trends Cardiovasc Med. 2020 10; 30(7):433-439.
    View in: PubMed
    Score: 0.105
  6. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2019 09; 12(9):e007414.
    View in: PubMed
    Score: 0.104
  7. Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans. J Cardiovasc Transl Res. 2019 06; 12(3):221-230.
    View in: PubMed
    Score: 0.099
  8. The efficacy of coronary sinus reducer in patients with refractory angina-A systematic review of the literature. J Interv Cardiol. 2018 Dec; 31(6):775-779.
    View in: PubMed
    Score: 0.097
  9. Slow/Fast Atrioventricular Nodal Reentrant Tachycardia Using the Inferolateral Left Atrial Slow Pathway: Role of the Resetting Response to Select the Ablation Target. Circ Arrhythm Electrophysiol. 2018 09; 11(9):e006631.
    View in: PubMed
    Score: 0.097
  10. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
    View in: PubMed
    Score: 0.088
  11. Intermittent vs. Continuous Anticoagulation theRapy in patiEnts with Atrial Fibrillation (iCARE-AF): a randomized pilot study. J Interv Card Electrophysiol. 2017 Jan; 48(1):51-60.
    View in: PubMed
    Score: 0.085
  12. Spectral Analysis of Electrocardiograms in Patients with Inducible Atrial Fibrillation after Catheter Ablation Predicts Sinus Rhythm Maintenance. Ann Noninvasive Electrocardiol. 2017 Jan; 22(1).
    View in: PubMed
    Score: 0.083
  13. Risk of coronary artery injury with radiofrequency ablation and cryoablation of epicardial posteroseptal accessory pathways within the coronary venous system. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):113-9.
    View in: PubMed
    Score: 0.070
  14. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8.
    View in: PubMed
    Score: 0.068
  15. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace. 2012 Oct; 14(10):1490-7.
    View in: PubMed
    Score: 0.063
  16. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8.
    View in: PubMed
    Score: 0.059
  17. Transesophageal echocardiography for the diagnosis of pulmonary vein stenosis after catheter ablation of atrial fibrillation: a systematic review. Echocardiography. 2010 Oct; 27(9):1141-6.
    View in: PubMed
    Score: 0.056
  18. Same-day discharge for left atrial appendage occlusion procedure: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023 May; 34(5):1196-1205.
    View in: PubMed
    Score: 0.033
  19. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2023 Mar; 66(2):493-506.
    View in: PubMed
    Score: 0.032
  20. Neuroscientific therapies for atrial fibrillation. Cardiovasc Res. 2021 06 16; 117(7):1732-1745.
    View in: PubMed
    Score: 0.029
  21. Low-Level Tragus Stimulation Modulates Atrial Alternans and Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation. J Am Heart Assoc. 2021 06 15; 10(12):e020865.
    View in: PubMed
    Score: 0.029
  22. A serendipitous identification of a lead extraction complication. Echocardiography. 2014 Sep; 31(8):E247-9.
    View in: PubMed
    Score: 0.018
  23. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214.
    View in: PubMed
    Score: 0.017
  24. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm. 2013 Mar; 10(3):428-35.
    View in: PubMed
    Score: 0.016
  25. Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience. J Invasive Cardiol. 2012 Jan; 24(1):1-3.
    View in: PubMed
    Score: 0.015
  26. Culprit-vessel percutaneous coronary intervention followed by contralateral angiography versus complete angiography in patients with ST-elevation myocardial infarction. Tex Heart Inst J. 2012; 39(3):359-64.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.